Testing effectiveness (Phase 2)UnknownNCT03050866
What this trial is testing
Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)
Who this might be right for
Circulating Tumor CellMetastatic Prostate Cancer
Erasmus Medical Center 140